The NIHR BioResource has therefore today taken the decision to no longer recruit new participants to its panel. This includes:
- The enrolment of members of the public who have expressed an interest in joining the BioResource
- The recruitment of patients with a Rare Disease, IBD, NAFLD or IMID, and through recruiting sites and clinics.
Existing BioResource participants who have been invited, or have accepted, to participate in research studies will also be notified. Apart from research studies through online questionnaires, other recall activities will be on hold until further notice.
As of today, staff members of the NIHR BioResource who are based in Cambridge are now working from home. Our ability to respond may be affected by our remote working and/or the impact of a wider COVID-19 infection. Some individual phone numbers and emails are no longer being monitored on a regular basis. Please try emailing staff members in the first instance if you need to reach any of us in particular.
Please do not hesitate to contact us on 0800 090 22 33 or email@example.com, if you have any query regarding the above.
Thank you for your understanding.
Please stay safe.
Nathalie Kingston, PhD
Director – NIHR BioResource for Translational Research
First published 17 March 2020